← All trials
NCT00222235
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2000
- Primary completion
- —
- Completion date
- Jun 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- University of MarylandLead sponsor
- University of MarylandStudy chair
- National Institute of Mental Health (NIMH)Collaborator
- The Zucker Hillside HospitalCollaborator
- University of California, Los AngelesCollaborator
- Sarah Herzog HospitalCollaborator
- New York UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.